GlassScriptPhysician profile
Gary S Orris
NPI 1770556276
$12,593.72
in general payments reported to CMS, 2019-2025
33 companies · $477 in 2025
The $477 reported for 2025 was more than what 83% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $1,141 · 2021: $1,242 · 2022: $847 · 2023: $7,288 · 2024: $868 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $6,185 · Food and Beverage: $2,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $6,184.60 |
| Food and Beverage | $2,447.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,464.36 | 2022-2024 | Venaseal, Closurefast |
| Lilly USA, LLC | $870.08 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $705.15 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $569.20 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Supernus Pharmaceuticals, INC. | $530.97 | 2022-2024 | Qelbree, Qelbree |
| Abbvie INC. | $522.61 | 2019-2025 | |
| Novo Nordisk INC | $439.96 | 2019-2022 | |
| Pfizer INC. | $332.10 | 2019-2025 | |
| Boston Scientific Corporation | $232.98 | 2021-2025 | Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $231.26 | 2019-2023 | |
| Exact Sciences Corporation | $184.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $176.28 | 2019-2022 | |
| Amgen INC. | $148.84 | 2019-2024 | Repatha, Otezla, Krystexxa |
| Becton, Dickinson and Company | $135.91 | 2024-2025 | Venclose Maven Catheter |
| Inspire Medical Systems, INC. | $124.92 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $119.65 | 2024-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $113.34 | 2020-2022 | |
| Astellas Pharma US INC | $111.67 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $86.82 | 2025 | Venclose Maven Catheter |
| Eisai INC. | $72.42 | 2024-2025 | |
| Medtronic Vascular, INC. | $58.81 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.18 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $53.86 | 2020-2022 | |
| Adlon Therapeutics L.P. | $48.90 | 2021 | |
| Aytu Biopharma, INC. | $37.51 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $27.81 | 2022-2023 | Quviviq |
| Saluda Medical Americas, INC. | $22.83 | 2024 | Evoke |
| Otsuka America Pharmaceutical, INC. | $22.17 | 2023 | Rexulti |
| Bioventus LLC | $20.94 | 2019 | |
| Linus Health, INC. | $19.95 | 2023 | |
| Arbor Pharmaceuticals, INC. | $18.99 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.61 | 2019 | |
| Daiichi Sankyo INC. | $16.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Orris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.